Using magnetic nanoparticles to heat and treat deep-seated cancers
Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic Hyperthermia
['FUNDING_R01'] · OREGON STATE UNIVERSITY · NIH-10775693
This study is exploring a new way to treat hard-to-reach tumors using tiny magnetic particles that can be delivered through your blood; when a special magnetic field is applied, these particles heat up to help destroy cancer cells or make them easier to treat with other therapies.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON STATE UNIVERSITY (nih funded) |
| Locations | 1 site (CORVALLIS, UNITED STATES) |
| Trial ID | NIH-10775693 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative magnetic nanoparticles that can be delivered through the bloodstream to target deep-seated tumors. By applying a non-invasive external magnetic field, these nanoparticles generate heat that can kill cancer cells or make them more vulnerable to other treatments like chemotherapy and radiation. The goal is to create a method that allows for effective treatment of tumors that are difficult to reach with traditional therapies. The research team consists of experts in nanomedicine and cancer treatment, working together to enhance the effectiveness of cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with deep-seated primary or metastatic tumors that are currently difficult to treat with conventional methods.
Not a fit: Patients with localized tumors that can be easily accessed and treated with existing therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for patients with hard-to-reach cancers.
How similar studies have performed: Previous studies have shown promise in using magnetic hyperthermia for cancer treatment, but this approach aims to expand its application to deeper tumors, making it a novel endeavor.
Where this research is happening
CORVALLIS, UNITED STATES
- OREGON STATE UNIVERSITY — CORVALLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TARATULA, OLEH — OREGON STATE UNIVERSITY
- Study coordinator: TARATULA, OLEH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer